| Abstract: |
Background and Purpose: Energy-based hemostasis of the prostatic vascular pedicles (PVP) during robot-assisted radical prostatectomy (RARP) may cause collateral thermal injury to adjacent neural tissue and has been shown to negatively impact sexual function recovery. The unique engineering design of the EnSeal® (Ethicon, Cincinnati, OH) has been demonstrated to limit collateral thermal tissue damage to <1.0mm. Use of tissue and instrument cooling before and during device activation may potentially further reduce thermal spread. As such, we sought to evaluate the collateral tissue effects of EnSeal with or without cold saline irrigation (CSI) during PVP control. Patients and Methods: The EnSeal Trio device was used for PVP control in 20 consecutive men undergoing bilateral, non-nerve-sparing RARP. Ipsilateral vascular pedicles were randomly selected to EnSeal plus CSI (<4°C) application to the tissue before and during device activation or EnSeal alone. The primary end point was the distance of thermal injury from the inked margin using both hematoxylin and eosin (H&E) and terminal transferase uridyl nick end-labeling (TUNEL) apoptosis staining. A mean of three measurements was taken for each pedicle. Pathologic analysis was performed by a single, blinded uropathologist. Results: Mean distance of thermal injury from the inked margin using H&E staining was 0.31mm (range 0.15-0.40mm) and 0.98mm (range 0.7-1.2mm) for the EnSeal plus CSI and EnSeal alone, respectively (P<0.0001). TUNEL staining also demonstrated lateral tissue damage of 0.39mm (range 0.2-0.5mm) and 1.12mm (range 0.9-1.3mm), respectively (P<0.001). No complications related to hemostasis or postoperative bleeding were observed in the study. Conclusions: The hemostatic properties of EnSeal work effectively when submerged in CSI. Adjacent thermal tissue damage is significantly minimized with the addition of CSI. This may have a beneficial impact on nerve preservation and sexual function outcomes after RARP. Copyright © 2010, Mary Ann Liebert, Inc. |
